Bioabsorbable Vascular Scaffolds Market growing at a CAGR of 11.8% over the fore

Posted by Shristi on October 4th, 2019

Analyst Speak: 

“The Global Bioabsorbable Vascular Scaffolds Market was valued at US$ 184.2 Mn in 2018 and is expected to grow at a significant CAGR over six years forecast period 2019-2025 owing to increasing number of cardiovascular diseases and rising investments in research and development”

Precision Business Insights (PBI) in its report titled “Global Bioabsorbable Vascular Scaffolds Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2018 and Forecast 2019-2025” assesses the market performance over six years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global bioabsorbable vascular scaffolds market was valued at US$ 184.2 Mn in 2018 and growing at a CAGR of 11.8% over the forecast period owing to rising elderly population and increasing incidences of cardiac diseases coupled with rising number of cardiac procedures. According to American College of Cardiology, Cardiovascular disease (CVD) remains the leading cause of death in the United States, responsible for 840,768 deaths (635,260 cardiac) in 2016. From 2006 to 2016, the US death rate from CVD decreased by 18.6% and from coronary heart disease by 31.8%. In the United States in 2019, coronary events are expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events. Moreover, rising prevalence of obesity and advancements in technology for the development of new products are expected to enhance the growth of the market. However, slow adoption of stents and lack of reimbursement policies are expected to restrain the growth of the market.

Avail Sample Report of the Market @ https://www.precisionbusinessinsights.com/request-sample?product_id=15795 

Global bioabsorbable vascular scaffolds market segmented on the basis of product type, material type, application, end user, and region.               

Coronary Artery Stents segment accounted for higher revenue share

Based on application, global bioabsorbable vascular scaffolds market segmented into Coronary Artery Stents ad Peripheral Artery Stents. Coronary Artery Stents segment market accounted US$ XX Mn in 2018 and projected to dominate over the forecast period due to the increasing adoption of stents and increasing adoption towards novel products in the market and various number of products in the pipeline are expected to fuel the growth of the market of the over the forecast years.

North America is expected to dominate Global Bioabsorbable Vascular Scaffolds Market 

PBI’s global bioabsorbable vascular scaffolds market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America is expected to account for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to rising awareness about the treatment of coronary disorders in bioabsorbable vascular stents, and products available in the pipeline help in the growth of global bioabsorbable vascular scaffolds market. Asia Pacific region exhibits significant growth rate owing to change in lifestyle, developing healthcare infrastructure, increasing geriatric population. Europe is expected to show highest CAGR over the forecast years owing to increasing elderly population in the region and advancements in technology in the developed countries such as Germany, UK, and France etc.

For More Information @ https://www.precisionbusinessinsights.com/market-reports/global-bioabsorbable-vascular-scaffolds-market/

Key Developments   

• In April 2017, REVA Medical’s Fantom sirolimus-eluting bioresorbable scaffold received CE mark
• In July 2016, FDA has approved the Absorb GT Bioresorbable Vascular Scaffold (BVS) System manufactured by Abbott Vascular, Inc
• In January 2016, Svelte Medical announced the European launch of low profile drug-eluting stent resulting in smaller delivery catheter and easier implantation

Key player’s profiles in the report are Medtronic (U.S.), Abbott Laboratories (U.S), Boston Scientific Corporation (U.S.), Biosensors International Group, Ltd. (Singapore), Biotronik SE & Co. KG (Germany), C.R. Bard Inc. (U.S.), Stentys SA (France), Svelte Medical Systems, Inc. (U.S.), and REVA Medical, Inc. (U.S.).

Detailed Segmentation 

By Product Type    

• Synthetic
• Biological
• Biosynthetic

By Material Type    

• Metal based BVS
• Polymer based BVS

By Application   

• Coronary Artery Stents
• Peripheral Artery Stents

By End User

• Hospitals
• Cardiac Centres
• Ambulatory Surgical Centres

Geography 

North America

• US
• Canada

Europe

• Germany
• France
• UK
• Italy
• Spain
• Russia
• Poland
• Rest of Europe

Asia-Pacific

• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Venezuela
• Rest of Latin America

Middle East and Africa (MEA)

• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

About Us:
 
Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.
 
Contact Us:
 
Shreya Paul
Senior Business Development Executive
Email @ shreya@precisionbusinessinsights.com
Call @ +1-866-598-1553
Precision Business Insights